The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ANTI-CD40 BINDING MOLECULES HAVING ENGINEERED FC DOMAINS AND THERAPEUTIC USES THEREOF

Application EP-3856790-A4

European Patent Office

ANTI-CD40 ANTIBODIES IN COMBINATION AND METHODS OF USE

Application EP-3534951-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.